Director/PDMR Shareholding
Cambridge Antibody Tech Group PLC
30 December 2005
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
Cambridge Antibody Technology Group plc
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
John Aston
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
As in 3. above
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
As in 3. above
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
Ordinary 10 Pence Shares
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
Greenwood Nominees Limited
8 State the nature of the transaction
Allotment and issue of new shares in the Company issued at the average mid
market quotation as derived from the Daily Official List for the three business
days preceding 30 December 2005 such shares having been acquired for the purpose
of the Matching Share element of the Executive Incentive Plan.
9. Number of shares, debentures or financial instruments relating to shares
acquired
3,816
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.007%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
£6.976
14. Date and place of transaction
30 December 2005
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
76,556
16. Date issuer informed of transaction
30 December 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
30 December 2005
18. Period during which or date on which it can be exercised
30 December 2008 to 29 December 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
11,448 Ordinary 10 Pence Shares
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 pence per share under option
22. Total number of shares or debentures over which options held following
notification
124,988 of which:
14,161 are options under the Company Share Option Plan
82,507are Restricted Shares under the Executive Incentive Plan
28,329 are Matching Shares under the Executive Incentive Plan
23. Any additional information
Generally speaking all shares under option are subject to performance
conditions, details of which can be obtained from the office of the Company
Secretary
24. Name of contact and telephone number for queries
Justin Hoskins 01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
Justin Hoskins, Company Secretary
Date of notification
30 December 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
Cambridge Antibody Technology Group plc
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
Peter Chambre
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
As in 3. above
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
As in 3. above
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
Ordinary 10 Pence Shares
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
Greenwood Nominees Limited
8 State the nature of the transaction
Allotment and issue of new shares in the Company issued at the average mid
market quotation as derived from the Daily Official List for the three business
days preceding 30 December 2005 such shares having been acquired for the purpose
of the Matching Share element of the Executive Incentive Plan.
9. Number of shares, debentures or financial instruments relating to shares
acquired
2,150
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.004%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
£6.976
14. Date and place of transaction
30 December 2005
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
28,592
16. Date issuer informed of transaction
30 December 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
30 December 2005
18. Period during which or date on which it can be exercised
30 December 2008 to 29 December 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
6,450 Ordinary 10 Pence Shares
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 pence per share under option
22. Total number of shares or debentures over which options held following
notification
387,522 of which:
191,969 are options under the Company Share Option Plan
145,021 are Restricted Shares under the Executive Incentive Plan
50,532 are Matching Shares under the Executive Incentive Plan
23. Any additional information
Generally speaking all shares under option are subject to performance
conditions, details of which can be obtained from the office of the Company
Secretary
24. Name of contact and telephone number for queries
Justin Hoskins 01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
Justin Hoskins, Company Secretary
Date of notification
30 December 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
Cambridge Antibody Technology Group plc
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
Alexander Duncan
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
As in 3. above
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
As in 3. above
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
Ordinary 10 Pence Shares
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
Greenwood Nominees Limited
8 State the nature of the transaction
Allotment and issue of new shares in the Company issued at the average mid
market quotation as derived from the Daily Official List for the three business
days preceding 30 December 2005 such shares having been acquired for the purpose
of the Matching Share element of the Executive Incentive Plan.
9. Number of shares, debentures or financial instruments relating to shares
acquired
716
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.001%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
£6.976
14. Date and place of transaction
30 December 2005
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
15,155
16. Date issuer informed of transaction
30 December 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
30 December 2005
18. Period during which or date on which it can be exercised
30 December 2008 to 29 December 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
2,148 Ordinary 10 Pence Shares
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 pence per share under option
22. Total number of shares or debentures over which options held following
notification
66,951 of which:
31,776 are options under the Company Share Option Plan
29,640 are Restricted Shares under the Executive Incentive Plan
5,535 are Matching Shares under the Executive Incentive Plan
23. Any additional information
Generally speaking all shares under option are subject to performance
conditions, details of which can be obtained from the office of the Company
Secretary
24. Name of contact and telephone number for queries
Justin Hoskins 01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
Justin Hoskins, Company Secretary
Date of notification
30 December 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
Cambridge Antibody Technology Group plc
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
Lynn Lester
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
As in 3. above
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
As in 3. above
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
Ordinary 10 Pence Shares
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
Greenwood Nominees Limited
8 State the nature of the transaction
Allotment and issue of new shares in the Company issued at the average mid
market quotation as derived from the Daily Official List for the three business
days preceding 30 December 2005 such shares having been acquired for the purpose
of the Matching Share element of the Executive Incentive Plan.
9. Number of shares, debentures or financial instruments relating to shares
acquired
286
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0005%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
£6.976
14. Date and place of transaction
30 December 2005
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
2,710
16. Date issuer informed of transaction
30 December 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
30 December 2005
18. Period during which or date on which it can be exercised
30 December 2008 to 29 December 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
Ordinary 10 Pence Shares
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 pence per share under option
22. Total number of shares or debentures over which options held following
notification
25,764 of which:
12,361 are options under the Company Share Option Plan
10,421 are Restricted Shares under the Executive Incentive Plan
2,982 are Matching Shares under the Executive Incentive Plan
23. Any additional information
Generally speaking all shares under option are subject to performance
conditions, details of which can be obtained from the office of the Company
Secretary
24. Name of contact and telephone number for queries
Justin Hoskins 01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
Justin Hoskins, Company Secretary
Date of notification
30 December 2005
END
This information is provided by RNS
The company news service from the London Stock Exchange
Friday, 10th January 2025
COMPANIES COVERED:
Latest directors dealings
- 2 days ago FRP Advisory Group
- 2 days ago Marks Electrical Group
- 2 days ago CLS Holdings
- 2 days ago QinetiQ Group
- 2 days ago Spectris